Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inhibin beta A chain (encoded by the INHBA gene) is a subunit that can homodimerize to form activin A, or heterodimerize with an alpha subunit to form inhibin A, or with a beta B subunit to form activin AB. Activin A is a secreted cytokine belonging to the transforming growth factor-beta (TGF-beta) superfamily. It plays critical roles in embryonic development, cell proliferation, apoptosis, immune response, and tissue homeostasis. Pathologically, overexpressed activin A is implicated in cancer progression, metastasis, cachexia, and pulmonary arterial hypertension (PAH). In fibrodysplasia ossificans progressiva (FOP), activin A aberrantly activates mutant ACVR1 receptors, driving progressive heterotopic ossification. Therapeutic strategies targeting this molecule include monoclonal antibodies like garetosmab, which specifically neutralize activin A, and soluble receptor-Fc fusion proteins (ligand traps) like sotatercept and STM-434, which sequester activin A and other TGF-beta ligands to restore signaling balance.
Inhibition of activin A signaling by binding and neutralizing the ligand (either via a monoclonal antibody or a soluble receptor-Fc ligand trap), thereby preventing its interaction with type I and type II activin receptors and restoring the balance of downstream SMAD signaling pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inhibin beta A chain (INHBA).